Literature DB >> 3280908

Aminoglycoside antibiotics in clinical use.

S J Pancoast1.   

Abstract

Aminoglycosides are among the most used antibiotics despite competitive pressure from newer beta-lactam agents. The activity profile, pharmacology, toxicity potential, and methods of toxicity prevention of aminoglycosides are well appreciated after three decades. Nephrotoxicity, ototoxicity, and the added costs of drug level monitoring limit wider usage, but great activity against highly antibiotic resistant gram negative bacteria often outweigh these disadvantages and will likely keep aminoglycosides available for the foreseeable future.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280908     DOI: 10.1016/s0025-7125(16)30760-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

1.  Aminoglycoside therapy: current and prospective uses.

Authors:  J E Leggett
Journal:  Tex Heart Inst J       Date:  1990

2.  Testing for high-level aminoglycoside resistance in enterococcal infections.

Authors:  B Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

3.  Changes in gentamicin pharmacokinetic profiles induced by mechanical ventilation.

Authors:  C Triginer; I Izquierdo; R Fernández; J Torrent; S Benito; A Net; F Jane
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Aminoglycoside therapy. Current use and future prospects.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

Review 5.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

6.  In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.

Authors:  J W Gu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation considered.

Authors:  R Janknegt
Journal:  Pharm World Sci       Date:  1993-08-20

Review 8.  Amikacin Therapy in Japanese Pediatric Patients: Narrative Review.

Authors:  Hideo Kato; Yukihiro Hamada
Journal:  Int J Environ Res Public Health       Date:  2022-02-10       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.